Fellowship · Birmingham, AL
Sponsored by University of Alabama Hospital
Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19.
JAMA · 2021 · 651 citations · Michele Kong
Neurologic Involvement in Children and Adolescents Hospitalized in the United States for COVID-19 or Multisystem Inflammatory Syndrome.
JAMA neurology · 2021 · 308 citations · Michele Kong
Multisystem Inflammatory Syndrome in Children - Initial Therapy and Outcomes.
The New England journal of medicine · 2021 · 293 citations · Michele Kong
Maternal Vaccination and Risk of Hospitalization for Covid-19 among Infants.
The New England journal of medicine · 2022 · 197 citations · Michele Kong
Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12-18 Years - United States, July-December 2021.
MMWR. Morbidity and mortality weekly report · 2022 · 229 citations · Michele Kong
Effectiveness of Maternal Vaccination with mRNA COVID-19 Vaccine During Pregnancy Against COVID-19-Associated Hospitalization in Infants Aged <6 Months - 17 States, July 2021-January 2022.
MMWR. Morbidity and mortality weekly report · 2022 · 178 citations ·
BNT162b2 Protection against the Omicron Variant in Children and Adolescents.
The New England journal of medicine · 2022 · 196 citations · Michele Kong
Effectiveness of BNT162b2 Vaccine against Critical Covid-19 in Adolescents.
The New England journal of medicine · 2022 · 162 citations · Michele Kong